Stock Price of Hologic, Inc. (HOLX) Decreases -2.46%

Stock price performance of Hologic, Inc. is analyzed for various periods using several stock trading signals. In this case, The stock price has rallied 7.73% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 3.23% . Looking at the past 52 week period, the stock price is up at 18.97% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of Hologic, Inc. has a positive value of 16.29 compared to overall market. For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a 20-day Moving Average of 1.53% and the 50-Day Moving Average is 2.92%.The 200 Day SMA reached 8.77%

Hologic, Inc. is having a Relative Strength Index of 47.13 which indicates the stock is not yet over sold or over bought based on the technical indicators. Hologic, Inc. (NASDAQ:HOLX) has tumbled 2.46% during the past week and has dropped 0.75% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 2.58%. Hologic, Inc. (NASDAQ:HOLX) has underperformed the index by 1.64% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

Company has reported several Insider transactions to the SEC, on Jan 5, 2017, Elaine Ullian (director) sold 9,351 shares at 40.00 per share price.On Jan 5, 2017, Nancy Leaming (director) sold 8,737 shares at 40.06 per share price.On Dec 16, 2016, Sally Crawford (director) sold 17,626 shares at 41.00 per share price.

Hologic Last issued its quarterly earnings results on Feb 1, 2017. The company reported $0.52 EPS for the quarter, beating the analyst consensus estimate by $ 0.01. Analyst had a consensus of $0.51. The company had revenue of $734.40 million for the quarter, compared to analysts expectations of $724.47 million. The companys revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 EPS.

Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Hologic was Initiated by Deutsche Bank on Jan 18, 2017 to Buy, Price Target of the shares are set at $48.Hologic was Upgraded by Piper Jaffray to Overweight on Jan 4, 2017.

Hologic, Inc. (NASDAQ:HOLX) : On Friday heightened volatility was witnessed in Hologic, Inc. (NASDAQ:HOLX) which led to swings in the share price. The stock opened for trading at $39.54 and hit $39.73 on the upside , eventually ending the session at $39.58, with a gain of 0.28% or 0.11 points. The heightened volatility saw the trading volume jump to 2,655,057 shares. The 52-week high of the share price is $41.24 and the company has a market cap of $11,052 million. The 52-week low of the share price is at $31.84 .

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment — a key element of womens health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.


Share this post

Leave a Reply